Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology PDC High-Throughput In Vitro Drug Efficacy Platform: Introduction of Technical Advantages

Author:

InnoModels

Release time:

2024-07-10

In the field of drug discovery and development, an efficient and accurate drug efficacy evaluation platform plays a crucial role in the successful development and clinical application of new drugs. With its unique technology and advantages, InnoModels' PDC high-throughput in vitro drug efficacy platform provides unprecedented accuracy and reliability for drug R&D and clinical treatment, and has become an important force leading the field of drug evaluation.
1、Highly consistent primary cells
The core of InnoModels' PDC high-throughput in vitro drug efficacy platform lies in its ability to utilize cutting-edge technology to obtain highly consistent primary cells with the patient from the digested products of the PDX (human-derived tumor xenograft) model. Such cells not only retain complex cell subpopulations and biological characteristics, but also more closely resemble the clinical situation, allowing for more realistic and reliable drug action and response. Through this platform, researchers can simulate the clinical environment in vitro for drug screening and efficacy evaluation, providing powerful technical support for new drug development.
2. Pharmacodynamic response and clinical relevance
The PDC high-throughput in vitro drug efficacy platform is not only applicable to the screening of test drugs and models, but also capable of predicting the clinical efficacy of drugs. By comparing the subject drug with counterpart drugs (e.g., drugs with similar mechanism of action or standardized therapeutic drugs), researchers can predict the clinical value of the drug and provide a scientific basis for further development and application of the drug. This highly clinically relevant drug efficacy evaluation helps to reduce the risk and cost of new drug development and improve the success rate of R&D.

3、Multi-dimensional application
The PDC high-throughput in vitro drug efficacy platform of InnoModels Biotechnology has a wide range of applications, not only for drug screening, but also in multiple dimensions. For example, by comparing the efficacy rates of different cancer models, the indications of drugs can be determined; by comparing the differences in genetic characteristics between sensitive and resistant models, biomarkers that can predict drug efficacy can be searched. In addition, the platform can be used in the field of personalized medicine to provide patients with more precise treatment plans.
4、Efficient Data Processing Capability
Equipped with an advanced data analysis system, the InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform is capable of automated processing and analysis of experimental data, greatly improving the efficiency and accuracy of data processing. Researchers can intuitively understand the experimental results through the visualization reports provided by the platform, thus better guiding the subsequent research work. This efficient data processing capability makes the drug development process more efficient and convenient.
5、Lead the innovation in the field of drug evaluation
The emergence of the InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform has brought unprecedented precision and reliability to drug development and clinical treatment. The platform not only focuses on drug screening, but also pays more attention to the prospect of drug clinical application. Through continuous technological innovation and optimization, the platform will inject more innovation and progress into the field of drug evaluation and promote the continuous development of the drug R&D field.
In conclusion, with its unique technology and advantages, InnoModels Biotechnology PDC high-throughput in vitro drug efficacy platform provides powerful technical support for drug development and clinical treatment. With the continuous development of the biopharmaceutical field, the platform will play a greater role in the future, injecting more confidence and momentum for the success of new drug development and clinical application.

InnoModels Biotechnology bioidentical models: what are the main features

InnoModels Biotechnology ADCC platform: what are the key features

InnoModels Biotechnology bioidentical models: what are the main features

InnoModels Biotechnology ADCC platform: what are the key features

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License